People channel feed

Bio­phar­ma’s 20 high­est-paid CEOs of 2023, earn­ing $20M+ pay pack­ages

Last year

Pfiz­er CSO Mikael Dol­sten to de­part af­ter 15 years lead­ing drug gi­ant's R&D

Last year

Apol­lomics plans to lay off staff, nar­row fo­cus for lung can­cer tri­al

Last year
R&D

Fol­low­ing a piv­otal tri­al fail and lay­offs, Ovid finds it­self in a fa­mil­iar spot

Last year
R&D

Take­da to lay off more em­ploy­ees in Mass­a­chu­setts

Last year
Pharma

Aerovate plans to lay off near­ly all em­ploy­ees af­ter tri­al fail­ure

Last year
R&D
Pharma

Q&A: Ver­tex’s pain re­search chief on mov­ing be­yond opi­oids, AI and how phar­ma ac­qui­si­tions thrive or fail

Last year
R&D

Gink­go to cut at least 35% of staff in mul­ti-year re­struc­tur­ing plan

Last year
Pharma

Bio­phar­ma lead­ers chart­ing a path for the in­dus­try's LGBTQ+ com­mu­ni­ty

Last year
Special

Lil­ly cracks down fur­ther on com­pound­ed tirzepatide as GLP-1 short­age starts to ease

Last year
Law

Stephen Squin­to talks writ­ing checks and next-gen obe­si­ty drugs as JP Mor­gan clos­es first $500M+ biotech fund

Last year
Financing

Bill Haney gives up CEO post at Sky­hawk, be­comes chair­man; Bay­er parts ways with head of biotech

Last year
Peer Review

Barinthus Bio to lay off 25% of its work­force and fo­cus on just two pro­grams

Last year
R&D

Cor­rect­ed: Life sci­ence com­pa­ny Ag­i­lent cuts over 180+ em­ploy­ees in Cal­i­for­nia 

Last year
Manufacturing

Teladoc names in­sur­ance ex­ec­u­tive as new CEO

Last year
Health Tech

Google's par­ent com­pa­ny Al­pha­bet poach­es Eli Lil­ly CFO; More changes at Ex­sci­en­tia

Last year
Peer Review

For­mer Sanofi R&D leader Frank Nes­tle to lead Deer­field’s grow­ing drug dis­cov­ery arm

Last year
R&D

Amarin names new CEO as Patrick Holt de­parts

Last year

BioN­Tech co-founder Özlem Türe­ci on ‘hip’ AD­Cs and the pow­er of com­bo ther­a­pies

Last year
R&D
Cell/Gene Tx

Neu­ro­crine CEO Kevin Gor­man to re­tire af­ter 32-year run; Blue­bird picks up fifth CFO in three years

Last year
Peer Review

Ike­na On­col­o­gy weighs ‘strate­gic op­tions’ as it drops can­cer as­set, trims head­count to save cash

Last year
R&D

Joe Panet­ta to step down as Bio­com Cal­i­for­nia CEO

Last year

Take­da to lay off 640 work­ers in Mass­a­chu­setts as part of mul­ti­year over­haul

Last year

Af­ter 14 years call­ing part­ner­ing shots at Genen­tech/Roche, James Sabry is head­ed back in­to the biotech fray

Last year
Bioregnum
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times